Science Explorer Interactive view Map
Company · Cambridge · United States

DecImmune Therapeutics (United States)

decimmune.com/index.htmlROR OpenAlex
Research works
45
▲ 186% vs 2013–17
Citations
1.4k
31.6 per fractional work
Top-10% rate
24.3%
record average 16.5%
Open access
62%
world 28%

Not ranked overall: DecImmune Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.86× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 13.94× its world share, 3 worksImmunology and Micro…Neuroscience: 6.84× its world share, 2 worksNeuroscienceEngineering: 0.28× its world share, 1 worksEngineeringHealth Professions: 0.38× its world share, 0 worksHealth ProfessionsMedicine: 2.27× its world share, 9 worksMedicinePsychology: 0.06× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.9×. Every wedge is a field page.

Which keywords describe research at DecImmune Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies and Antibody Engineering.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Cancer Immunotherapy4▲ 138×3 topics
  2. Immunotherapy4▲ 23×3 topics
  3. CAR T Cells3▲ 213×1 topic
  4. Chimeric Antigen Receptor3▲ 213×1 topic
  5. Glycosylation3▲ 121×3 topics
  6. Monoclonal Antibodies3▲ 150×3 topics
  7. Therapeutic Antibodies2▲ 155×2 topics
  8. Antibody Engineering2▲ 184×1 topic
  9. Fc Receptors2▲ 184×1 topic
  10. Innate Immunity2▲ 29×4 topics
  11. Hearing Loss2▲ 61×3 topics
  12. Immunity2▲ 18×3 topics
  13. Cancer1▲ 4.8×10 topics
  14. Neural Plasticity1▲ 34×3 topics
  15. Antigen Presentation1▲ 62×1 topic
  16. Dendritic Cells1▲ 61×1 topic
  17. Neurological Disorders1▲ 8.8×5 topics
  18. Cochlear Neuropathy1▲ 171×1 topic
  19. Tinnitus1▲ 171×1 topic

Which research topics does DecImmune Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses and Hearing, Cochlea, Tinnitus, Genetics.

CAR-T cell therapy resea…3CAR-T cell therapy research: 3 fractional worksMonoclonal and Polyclona…2Monoclonal and Polyclonal Antibodies Research: 2 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksHearing, Cochlea, Tinnit…1Hearing, Cochlea, Tinnitus, Genetics: 1 fractional worksRNA and protein synthesi…1RNA and protein synthesis mechanisms: 1 fractional worksViral Infectious Disease…1Viral Infectious Diseases and Gene Expression in Insects: 1 fractional worksBiosimilars and Bioanalytical Methods: 1 fractional worksRNA regulation and disease: 1 fractional worksT-cell and B-cell Immunology: 0 fractional worksRNA modifications and cancer: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingImmunologySensory Systems1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 3 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 Immunotherapy and Immune Responses Immunology 1 works
  4. 4 Hearing, Cochlea, Tinnitus, Genetics Sensory Systems 1 works
  5. 5 RNA and protein synthesis mechanisms Molecular Biology 1 works
  6. 6 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 1 works
  8. 8 RNA regulation and disease Molecular Biology 1 works
  9. 9 T-cell and B-cell Immunology Immunology 0 works
  10. 10 RNA modifications and cancer Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available61.6%not open38.4%

World: 28% of research is openly available.

with international co-authors31.3%domestic only68.7%

World: 19% is written across borders.

How has DecImmune Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 186% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.